People Mangala Srinivas

Contact

Mangala Srinivas PhD

contact

Mangala Srinivas assistant professor

Mangala started her career in research at the National University of Singapore, before completing her Ph.D. at Carnegie Mellon University (USA). Her work focuses on contrast agents for in vivo imaging.

read more

Mangala Srinivas assistant professor

Mangala started her career in research at the National University of Singapore, before completing her Ph.D. at Carnegie Mellon University (USA). Her work focuses on contrast agents for in vivo imaging. Mangala's early work helped established the field of 19F MRI for quantitative in vivo cell tracking, including the first paper on the topic. More recently, her group works on customisable nanoparticles for imaging and advanced personalised medicine applications. Some of these nanoparticles will be tested in a clinical cell tracking study using multimodal imaging, in melanoma patients. Her group works with fluorescence, MRI, PET, SPECT, ultrasound and photoacoustic imaging in various disease models. A spin-off to bring the nanoparticles to the patient on a larger scale is being set-up. This multidisciplinary work is supported by prestigious grants such as an NWO Veni and an ERC Starting Grant, among others. Mangala is also active within the Young Academy of Europe, and is currently elected to the board as Vice Chair. She is also an Associate Editor for the journal European Reviews.

Personal prizes & awards National & international

  • 2017: ERA-NET cardiovascular disease grant for 800k
  • STW Open Technology grant
read more

Personal prizes & awards National & international

  • 2017: ERA-NET cardiovascular disease grant for 800k
  • STW Open Technology grant
  • Dutch Venture Challenge
  • ERC Proof of Concept grant
  • ERC Starting Grant
  • NWO Veni

Social media


Field of study

Tumour Immunology Lab

Research group Multiscale Imaging

Mangala Srinivas's research group focuses on new types of contrast agents for multiple types of imaging.

read more

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more